Research programme: gene therapies - Human Genome Sciences/Genentech
Alternative Names: Gene-based therapies - Human Genome Sciences/GenentechLatest Information Update: 26 Oct 2005
Price :
$50 *
At a glance
- Originator Genentech; Human Genome Sciences
- Class
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Immunological disorders; Neurological disorders
Most Recent Events
- 26 Oct 2005 No development reported - Preclinical for Cancer in USA (unspecified route)
- 26 Oct 2005 No development reported - Preclinical for Immunological disorders in USA (unspecified route)
- 26 Oct 2005 No development reported - Preclinical for Neurological disorders in USA (unspecified route)